Progress in diagnosis and treatment in elderly patients with tuberculosis obstructive pulmonary disease

Volume 8, Issue 1, February 2023     |     PP. 1-16      |     PDF (391 K)    |     Pub. Date: January 15, 2023
DOI: 10.54647/biology180269    85 Downloads     4847 Views  

Author(s)

CAO Wen Li, Tuberculosis Department, Beijing Geriatric Hospital, Beijing 102699, China
Xuwei, Tuberculosis Department, Beijing Geriatric Hospital, Beijing 102699, China
Wu Jun-Feng, Tuberculosis Department, Beijing Geriatric Hospital, Beijing 102699, China
Wu Gui-Ping, Tuberculosis Department, Beijing Geriatric Hospital, Beijing 102699, China
Wu Li-Juan, Shijiazhuang People's Hospital, Respiratory Department, China
ShenNing, Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China
GAI Xiao Yan, Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China

Abstract
The obstructive pulmonary disease tuberculosis B (tuberculosis obstructive pulmonary called TOPD disease) in elderly patients with tuberculosis is a common and early prevention and treatment, the latter to irreversible persistent airflow limitation and accompanied by chronic airway inflammation, progressive misdiagnosed, TOPD patients are mostly male, 52% for nonsmokers, the incidence characteristics of TOPD has two kinds of disease, TOPD patients than in COPD patients more susceptible to hemoptysis, and its FVC value and lower FEV1/FEV value; and TOPD for the poor response to bronchodilator, airflow limitation in patients with TOPD irreversible airway resistance increased, accompanied by stronger airflow limitation; TOPD patients are not associated with airflow limitation were more susceptible to acute exacerbation. The diagnosis should be based on the history of high risk factors, clinical symptoms and signs, laboratory tests, and other comprehensive analysis and diagnosis of the data. AIDU

Keywords
Ba elderly; Tuberculosis; Obstructive pulmonary disease; Diagnosis; Drug therapy; Combination

Cite this paper
CAO Wen Li, Xuwei, Wu Jun-Feng, Wu Gui-Ping, Wu Li-Juan, ShenNing, GAI Xiao Yan, Progress in diagnosis and treatment in elderly patients with tuberculosis obstructive pulmonary disease , SCIREA Journal of Biology. Volume 8, Issue 1, February 2023 | PP. 1-16. 10.54647/biology180269

References

[ 1 ] SIDDHARTHAN T, GUPTE A, BARNES P J. Chronic Obstructive Pulmonary Disease Endotypes inLow- and Middle-Income Country Settings: Precision Medicine for All [J]. American journal ofrespiratory and critical care medicine, 2020, 202(2): 171-2.
[ 2 ] Vitmine D deficiency andthe risk of tuberclosis a meta-analysis Sao-Fa Xu YI Han Cao wen-li design,Development and Therapy 2017 :11 91-102
[ 3 ] Allwood BW,Myer L, Bateman E D. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults.Respiration 2013; 86: 76–85. Allwood BW, Gillespie R, Galperin-Aizenberg M, et al. Mechanism of airflow obstruction in tuberculosis-associated obstructive pulmonary disease (TOPD). Am J Respir Crit Care Med.2014;189:A5832.
[ 4 ] Xing, Z.; Sun, T.; Janssens, J.; Chai, D.; Liu, W.; Tong, Y.; Wang, Y.; Ma, Y.; Pan, M.; Cui, J.; et al. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey. Thorax. 2022. DOI:10.1136/thoraxjnl-2021-218345.
[ 5 ] Liang Y, Yangzom D, Tsokyi L, Ning Y, Su B, Luo S, Ma Cuo B, ChuTso M, Ding Y, Chen Y, Sun Y. Clinical and Radiological Features of COPD Patients Living at ≥3000 m Above Sea Level in the Tibet Plateau. Int J Chron Obstruct Pulmon Dis. 2021 Aug 26;16:2445-2454. doi: 10.2147/COPD.S325097. PMID: 34483657; PMCID: PMC8408343.
[ 6 ] Salvado M，Garcia-Vidal C.Mortality of Tuberculosis in very old people[J]. J Am Geriatr Soc， 2010， 58:18-22.
[ 7 ] Allwood BW， Gillespie R， Galperin-Aizenberg M， et al. Mechanism of airflow obstruction in tuberculosis-associated obstructive pulmonary disease (TOPD). Am J Respir Crit Care Med.2014;189:A5832.
[ 8 ] Tuberculosis Ronan F. O toole ,Shakti D.Shukla,E. Haydn Walters 2015(95)659-663
[ 9 ] Chakrabarti B， Calverley PM， Davies PD. Tuberculosis and itsincidence， special nature and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis.2007;2(3):263–272.
[ 10 ] Chenhuilan Misdiagnosis analysis of 21 cases of senile chronic obstructive pulmonary disease complicated with pulmonary tuberculosis [j] Chinese general practice, 2006, 9 (22): 1884
[ 11 ] Fanglanjun, panqili, Jiang Yong, et al Clinical analysis of 107 cases of senile pulmonary tuberculosis [j] Journal of practical medicine, 2006, 22 (23): 2771-2772
[ 12 ] Li Yong pounced Misdiagnosis analysis of 18 cases of senile lower lobe tuberculosis [j] Clinical misdiagnosis and mistreatment, 2004, 17 (12): 851-852
[ 13 ] Li Qi, jiangxiaoying, liangjianqin, et al Efficacy analysis of the regimen containing levofloxacin or moxifloxacin in the treatment of multi drug resistant pulmonary tuberculosis [j] Chinese Journal of tuberculosis, 2016,38 (6): 436-442
[ 14 ] Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003;97(11):1237–1242.
[ 15 ] Park JH, Na JO, Kim EK, et al. The prognosis of respiratory failure in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2001;5:963–967.
[ 16 ] Kim SJ, Lee J, Park YS, et al. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30(6):737–742.
[ 17 ] Liu Ye, Dai Bing, Su Jia, et al. A meta-analysis of the efficacy of family non-invasive ventilation in patients with severe chronic obstructive pulmonary disease at stable stage. Chinese Journal of tuberculosis and respiration, 2017, 40 (5): 354-362
[ 18 ] Clinical professional committee of China Anti Tuberculosis Association Annual report on the progress of clinical diagnosis and treatment of tuberculosis (2012) [j] Chinese Journal of tuberculosis, 2013, 35 (6): 405-426
[ 19 ] Wang Ruirong, Ju Yongli Clinical analysis of 51 cases of chronic obstructive pulmonary disease complicated with pulmonary tuberculosis, chin J respir crit care Med, 2012,11 (5): 494-497   
[ 20 ] She Qilu, Meng Weimin Treatment experience of COPD complicated with pulmonary tuberculosis and cor pulmonale, guide of China medicine, 2014,12 (29): 384-385
[ 21 ] Iovino F , Brouwer MC , van de Beek D , Molema G , Bijlsma JJ . Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease . Cell Microbiol . 2013 ; 15 ( 6 ): 870 - 881 .
[ 22 ] American Thoracic Society/Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med . 2000 ; 161 ( suppl ): S221 - S247 .
[ 23 ] Hale BG , Albrecht RA , García-Sastre A . Innate immune evasion strategies of influenza viruses . Future Microbiol . 2010 ; 5 ( 1 ): 23 - 41 .
[ 24 ] Sin DD , Tashkin D , Zhang X , et al . Budesonide and the risk of pneumonia: a meta-analysis of individual patient data . Lancet . 2009 ; 374 ( 9691 ): 712 - 719 .
[ 25 ] Singh S , Loke YK . Drug safety assessment in clinical trials: methodological challenges and opportunities . Trials . 2012 ; 13 : 138 .
[ 26 ] Kesten S , Plautz M , Piquette CA , Habib MP , Niewoehner DE . Premature discontinuation of patients: a potential bias in COPD clinical trials . Eur Respir J . 2007 ; 30 ( 5 ): 898 - 906 .
[ 27 ] McCarthy B,Csey D，Devane D，et al.Pulmonary rehabilitation for chronic obstructive pulmonary disease[j].Cochrane Database Syst Rev，2015，（2）：CD003793.DOI:10.1002/14651858.CD003793.pub3.